Selvita Reports Significant Recovery in H2 2024, Sees Promising Outlook for the Future
KRAKÓW, Poland, Nov. 21, 2024 /PRNewswire/ -- Selvita S.A. (WSE: SLV), one of the leading preclinical contract research organizations in Europe, has published its financial results for Q3 2024 and provided an update on its backlog for 2024 and 2025 …